Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang

Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang

10.1186/1749-8546-7-16

Saved in:

Bibliographic Details
Main Authors:	Wang, C, Lu, Y, Chen, Z, Liu, X, Lin, H, Zhao, H, Chen, J, Kwan, Y, Ngai, S
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	BMC 2020
Subjects:	4 aminobutyric acid albumin alpha 2 macroglobulin biliverdin blood clotting factor 13a Chinese drug cholinergic receptor stimulating agent complement component C3 complement component C4b gelsolin haptoglobin hemopexin kallidin phytosphingosine prothrombin qiangji jianli fang thromboxane B2 unclassified drug adult albumin blood level article clinical article controlled study drug effect female Fourier transform mass spectrometry high throughput screening human liquid chromatography male matrix assisted laser desorption ionization time of flight mass spectrometry metabolomics myasthenia gravis peptidomics proteomics two dimensional gel electrophoresis
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178143
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1186/1749-8546-7-16